Biotechnology Assets, S.A. (BME:BST)
Spain · Delayed Price · Currency is EUR 0.2210
-0.0080 (-3.49%)
Aug 7, 2026, 12:54 PM CET
Biotechnology Assets Revenue
In the year 2025, Biotechnology Assets had annual revenue of 3.09M EUR, down -2.10%. Biotechnology Assets had revenue of 2.11M in the half year ending December 31, 2025, a decrease of -2.80%.
Revenue
3.09M
Revenue Growth
-2.10%
P/S Ratio
4.96
Revenue / Employee
131.99K
Employees
26
Market Cap
17.01M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 3.09M | -66.33K | -2.10% |
| Dec 31, 2024 | 3.16M | 2.63M | 494.28% |
| Dec 31, 2023 | 531.24K | -2.08M | -79.68% |
| Dec 31, 2022 | 2.61M | -471.56K | -15.28% |
| Dec 31, 2021 | 3.09M | 560.72K | 22.21% |
| Dec 31, 2020 | 2.52M | 394.94K | 18.54% |
| Dec 31, 2019 | 2.13M | -21.19M | -90.87% |
| Dec 31, 2018 | 23.32M | 11.09M | 90.67% |
| Dec 31, 2017 | 12.23M | 10.92M | 831.88% |
| Dec 31, 2016 | 1.31M | 261.91K | 24.94% |
| Dec 31, 2015 | 1.05M | -830.20K | -44.15% |
| Dec 31, 2014 | 1.88M | 1.01M | 116.04% |
| Dec 31, 2013 | 870.46K | 427.29K | 96.42% |
| Dec 31, 2012 | 443.17K | 154.02K | 53.27% |
| Dec 31, 2011 | 289.15K | 151.18K | 109.57% |
| Dec 31, 2010 | 137.97K | -285.03K | -67.38% |
| Dec 31, 2009 | 423.00K | 193.00K | 83.91% |
| Dec 31, 2008 | 230.00K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Grifols | 7.42B |
| Almirall | 1.16B |
| Laboratorios Farmaceuticos Rovi | 773.05M |
| Faes Farma | 711.06M |
| Laboratorio Reig Jofre | 337.73M |
| Prim, S.A. | 250.65M |
| Atrys Health | 144.31M |
| Labiana Health | 76.44M |